Form 4: Ocular Therapeutix Chief Strategy Officer Sells Shares to Cover Tax Obligations

Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix, sold 1,832 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Sanjay Nayak, the Chief Strategy Officer of Ocular Therapeutix, Inc. (OCUL), sold 1,832 shares of common stock on August 23, 2024.
• The sale was executed at a weighted average price of $9.02 per share, with individual transactions ranging from $8.88 to $9.17.
• The sale was conducted under a pre-arranged automatic sale instruction adopted on February 21, 2024, to cover tax withholding obligations related to the vesting of restricted stock units on August 22, 2024.
• Following the transaction, Nayak directly owns 176,194 shares of Ocular Therapeutix common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not necessarily indicative of a positive or negative outlook.

Industry Context

This is a routine Form 4 filing related to insider selling to cover tax obligations, which is a common practice among corporate executives. It doesn't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates